Elucidating the Ligandability of Cancer Acquired Cysteines and Engineering MS2 Bacteriophage Virus-Like Particle for Targeted Drug Delivery Applications Apr 23, 2024 | Event
From phenotypic screens to therapeutic targets for myelin repair and immunomodulation Apr 23, 2024 | Event
Harnessing DCAF16 for Targeted Degradation of Nuclear-Restricted Proteins in Cancer Apr 5, 2024 | Event